This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Humira (adalimumab) medication. The contract is a firm-fixed-price delivery order with a ceiling value of $10,143.07 and a period of performance through January 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab), a prescription medication used to treat various autoimmune conditions. The contract has a ceiling value of $43,341.96 and a period of performance through April 30, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (Adalimumab) medication. The contract has a ceiling value of $15,136.80 and a period of performance through December 12, 2023. It is a firm-fixed-price contract type, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) medication. The contract has a ceiling value of $6,807.32 and is a firm-fixed price delivery order. It was awarded on August 27, 2024 with an ultimate completion date of August 28, 2024. The contract is not set aside for any special program. AmerisourceBergen, a major pharmaceutical distributor, will deliver the Humira medication to support the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,738.72, is for the supply of Humira (adalimumab) medication, a biologic drug used to treat autoimmune diseases. The contract is a firm-fixed-price, non-set-aside award with a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,641.68, is for the supply of Humira (adalimumab) medication. It is a firm fixed-price delivery order contract with a completion date of February 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (Adalimumab) medication, a specialty biologic drug used to treat various autoimmune conditions. The contract has a firm fixed price of $9,526.07 and a ceiling value of up to that amount. The delivery order is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Humira (adalimumab) pharmaceutical products. The contract has a ceiling value of $63,074.49 and a performance period ending on July 31, 2024. The contract is a firm-fixed-price type and is not designated as a set-aside for any specific business category. Amerisourcebergen, a major pharmaceutical distributor, will provide the Humira products to support the medical needs...
This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the specialty medication Humira (adalimumab) at a firm fixed price of $3,002.48. The contract has an ultimate completion date of January 3, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,850.69 and a period of performance through May 12, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...